Skip to main content
. 2019 Dec 3;9:18202. doi: 10.1038/s41598-019-54804-9

Figure 4.

Figure 4

Simulated median afatinib plasma concentration-time profiles after oral administration of 40 mg/day afatinib for different scenarios regarding the median and 95% prediction interval of the 1000 simulated profiles for a typical reference patient (age 66.7 years; BMI 21.8 kg/m2; AST 25.3 IU/L; Ccr 79.9 mL/min). The solid lines show the median values, and the shaded area is the 95% prediction interval.